You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

Citalopram hydrobromide - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for citalopram hydrobromide and what is the scope of freedom to operate?

Citalopram hydrobromide is the generic ingredient in two branded drugs marketed by Almatica, Mylan Pharms Inc, Forest Labs, Aurobindo Pharma, Chartwell Molecular, Hetero Labs Ltd Iii, Hikma, Pharm Assoc, Biovail Labs Intl, Abbvie, Amneal Pharms Ny, Apotex, Aurobindo, Cosette, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Pharms Ltd, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, and Torrent Pharms, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for citalopram hydrobromide. Forty-five suppliers are listed for this compound.

Drug Prices for citalopram hydrobromide

See drug prices for citalopram hydrobromide

Drug Sales Revenue Trends for citalopram hydrobromide

See drug sales revenues for citalopram hydrobromide

Recent Clinical Trials for citalopram hydrobromide

Identify potential brand extensions & 505(b)(2) entrants

Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all citalopram hydrobromide clinical trials

Pharmacology for citalopram hydrobromide
Medical Subject Heading (MeSH) Categories for citalopram hydrobromide
Anatomical Therapeutic Chemical (ATC) Classes for citalopram hydrobromide

US Patents and Regulatory Information for citalopram hydrobromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077534-002 Oct 3, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Ltd CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077141-002 Apr 10, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie CELEXA citalopram hydrobromide TABLET;ORAL 020822-004 Jul 17, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077048-001 Nov 16, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms Ny CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077289-003 Nov 30, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma CITALOPRAM HYDROBROMIDE citalopram hydrobromide SOLUTION;ORAL 077043-001 Dec 13, 2004 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.